Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « AffRegInc.i » - entrée « Kyoto »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Kyoto < Kyoto < Kyoto 606-8501  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000397 (2019) Hajime Yoshifuji [Japon]Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
000440 (2019) Shinji Akioka [Japon]Interleukin-6 in juvenile idiopathic arthritis.
000828 (2018) H. Nihira [Japon] ; K. Nakagawa [Japon] ; K. Izawa [Japon] ; T. Kawai [Japon] ; T. Yasumi [Japon] ; R. Nishikomori [Japon] ; M. Nambu [Japon] ; A. Miyagawa-Hayashino [Japon] ; T. Nomura [Japon] ; K. Kabashima [Japon] ; M. Ito [Japon] ; S. Iwaki-Egawa [Japon] ; Y. Sasahara [Japon] ; M. Nakayama [Japon] ; T. Heike [Japon]Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency.
000B71 (2017) Naoki Ishiguro [Japon] ; Tatsuya Atsumi [Japon] ; Masayoshi Harigai [Japon] ; Tsuneyo Mimori [Japon] ; Norihiro Nishimoto [Japon] ; Takayuki Sumida [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Ayako Nakasone [Japon] ; Nobuhiro Takagi ; Hisashi Yamanaka [Japon]Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i -k "Kyoto " 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i  \
                -Sk "Kyoto " \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Kyoto 
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021